Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 2Completed 2Available 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 3Observational 2Expanded_access 1

Sponsor

Cancer Type

Sarcoma 6

Conditions

Osteosarcoma 6Neoplasms, Bone Tissue 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
mifamurtide × Sarcoma × Clear all
NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting
60 enrolled
Sarcoma

Osteosarcoma, Neoplasms, Bone Tissue

NCT04571229 2026-05-11

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Available
Sarcoma

Osteosarcoma

NCT01459484 2024-05-20

ISG/OS-2

Italian Sarcoma Group

Phase 2 Completed
225 enrolled
Sarcoma

Osteosarcoma

NCT02441309 2019-09-13

MEMOS

University of Oxford

Phase 2 Terminated
8 enrolled 17 charts
Sarcoma

Osteosarcoma

NCT01194284 2017-01-19

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Takeda

Terminated
25 enrolled
Sarcoma

Osteosarcoma

NCT00631631 2014-05-14

Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

Millennium Pharmaceuticals, Inc.

Completed
205 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡